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Dear Sir,
Wale et al. present a comprehensive study of 99mTc-
methoxyisobutylisonitrile scintigraphy in cold thyroid nod-
ules (CTNs) [1]. They conclude that MIBI scintigraphy can
usefully exclude malignancy of nondiagnostic (Thy1) and
nonneoplastic (Thy2) lesions, but consider MIBI scintigraphy
as a second-line investigation in the management of CTNs
(see their Fig. 4) [1]. To expand this point, we suggest that
MIBI scintigraphy should be considered as a first-line inves-
tigation in the management of CTNs.
We assessed the clinical significance of 99mTc-MIBI scin-
tigraphy in the assessment of 104 patients with CTNs, in 14 of
whom the histological findings were malignant and in 90
benign [2]. When 99mTc-MIBI uptake was regarded as the
criterion of malignancy in 99mTc-MIBI scintigraphy, the accu-
racy using seven different methods was in the range
69.46 – 92.21 % [2]. There were six malignant cold nodules
based on histopathology which were considered as benign
nodules on fine-needle aspiration cytology (FNAC). All such
nodules showed some degrees of 99mTc-MIBI uptake [2]. The-
se findings are of particular interest considering the fact that our
previous study showed a sensitivity of FNAC of just 53.84 %
in the detection of malignancy of the thyroid as compared with
final histopathology in 198 thyroidectomized patients [3]. The
sensitivity in the current study was 66.66 % [2]. We also see a
number of cases of discrepancy between FNAC and 99mTc-
MIBI scintigraphy in our ongoing daily practice.
Therefore, based on these findings and previous evidence
[4] and the inadequate ability of FNAC to detect thyroid
malignancy [5], we believe that 99mTc-MIBI scintigraphy
may have a great impact on the management of CTNs, and
we recommend using this method in routine practice and
management of CTNs. On the other hand, there are different
A reply to this comment can be found at doi:10.1007/s00259-013-2642-1
A. Riazi
Department of Surgery, Bushehr Medical University Hospital,
Bushehr University of Medical Sciences, Bushehr, Iran
M. Kalantarhormozi
Division of Endocrinology, Department of Internal Medicine,
Bushehr Medical University Hospital, Bushehr University of
Medical Sciences, Bushehr, Iran
I. Nabipour :A. Ostovar
Department of Endocrinology, The Persian Gulf Tropical Medicine
Research Center, Bushehr University of Medical Sciences,
Bushehr, Iran
H. Javadi
Golestan Research Center of Gastroenterology and Hepatology
(GRCGH), Golestan University of Medical Sciences, Gorgan, Iran
M. Assadi (*)
The Persian Gulf Nuclear Medicine Research Center, Bushehr
University of Medical Sciences, Bushehr 3631, Iran
e-mail: assadipoya@yahoo.com
M. Assadi
e-mail: asadi@bpums.ac.ir
Eur J Nucl Med Mol Imaging (2014) 41:575–576
DOI 10.1007/s00259-013-2641-2
methods of 99mTc-MIBI scintigraphy acquisition (early, de-
layed or both; planar or SPECT) and interpretation (equal,
increased 99mTc-MIBI uptake or both) in the imaging of CTNs
with different results. However, we observed that when a
nodule with equal or increased 99mTc-MIBI uptake in delayed
views is considered a malignant lesion, the sensitivity is
100 % [2]. In addition, it should be noted that a reliable
judgement of 99mTc-MIBI uptake in CTNs less than 1 cm in
diameter cannot be made due to the limited resolution of
current gamma cameras.
Overall, we suggest a combination of FNAC and
MIBI scan as a routine diagnostic approach to CTNs.
The need for a pragmatic approach to the education and
training of medical practitioners and nuclear medicine
assistants and physicians to achieve a change in the manage-
ment of patients with CTNs is more important following this
evidence.
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